Online Bingo at Its Best, Thanks to Bingo Reviewer!

Bingo is one of the easiest games to learn to play, but what happens when you're new to both bingo and online gaming, and you still want to give online bingo a try?

2012-12-09

BELGRADE, SERBIA, December 09, 2012 (Press-News.org) There's quite a mishmash of bingo sites, different offers, warnings about some venues, good and bad player reviews, forum posts, bonuses and other features that new players should take into consideration before they can feel confident they've made the right choice of the online bingo room where they'll deposit their money and play.

In such a jungle where experience is an essential tool, there's a ray of light that delivers hope for those who are not willing to experiment and risk their money on just any bingo site; and the ray comes in shape of online bingo resource sites, which have earned their popularity and widespread respectability for a good reason: they help you choose your bingo site wisely.

One of the most comprehensive and easy to use bingo information sites out there is the UK's favorite Bingo Reviewer, where bingo players can find all the info they need to make their play as safe and enjoyable as possible. And who knows better than punters from the UK - the cradle of modern bingo! What they benefit from when using Bingo Reviewer is a whole variety of useful and highly informative content - reviews of online bingo sites, software providers, banking options, lists of sites that support specific payment methods, languages and currencies, interesting facts and events from the world of bingo, as well as always intriguing bingo articles.

One of the most important of its traits is the bingo forum, where players can ask questions, get assistance with some of their problems and help others by sharing their bingo experiences. And last but definitely not the least are online bingo bonuses and various promotions, competitions and special offers for Bingo Reviewer members, who thereby benefit from a bonus service that can make their playing experience even more exciting and engaging.

The welcoming atmosphere, user-friendliness and quality content of the site attract so many punters to explore what's in it for them - and once they join it, they never want to leave, says Nik Zugic, General Manager of Bingo Reviewer. He also underlined that the site's membership is growing by day, which means even more activity on the site and even more experiences to share.

"And it's all about sharing," says Zugic. "Bingo Reviewer shares the expert knowledge of its employees in the field of online bingo, bringing the pastime closer to players, but also helping the industry understand what it is our average player needs and wants to find out there."

So, the next time you feel the urge to give online bingo a try, or to test-drive a new site, drop by to Bingo Reviewer and see what's up there. Or rather, use the site to check the credibility of your venue of choice, and make sure you get the most for your hard-earned money, without ever having to think twice whether you've made the best choice!

Established in 2006, Bingo Reviewer (http://www.bingoreviewer.co.uk/) has over 270 online bingo reviews, 115+ no deposit bonuses and selection of over 100 free games.

ELSE PRESS RELEASES FROM THIS DATE:

Film Vet Ashaine Briscoe Enters the Spotlight with Quirky, Heartfelt New Shorts

2012-12-09

Filmmaker Ashaine Briscoe has just made her debut as a screenwriter, director, and producer--but to call her a novice would be an incredible oversight. In reality, Briscoe has been working in film for years, developing an almost preternaturally accomplished and diverse resume that includes credits as a Production Assistant, an Art Director, and more. She has worked on TV commercials and music videos, and her keen eye and visual flair have landed her design spots in leading glamour magazines. Now, however, it is Briscoe's time to shine, and to unleash the full extent of ...

Investigational agent targets gene signaling pathways to improve response for patients with CLL

2012-12-08

(ATLANTA, December 8, 2012) –The promising investigational targeted therapy ibrutinib and its mechanism of silencing gene communication pathways critical to the development of cancer may be an effective way to combat chronic lymphocytic leukemia (CLL), according to studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). CLL is a blood cancer that causes abnormal white blood cells called lymphocytes to accumulate in the blood, bone marrow, and in the lymph nodes or other organs, causing these organs to enlarge. Approximately 15,000 ...

Researchers develop novel 3-D culture system for inflammatory breast cancer

2012-12-08

SAN ANTONIO, TX (December 8, 2012)—Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment. Researchers at Fox Chase Cancer Center have developed a novel, 3D culture system that mimics the environment surrounding these cancer cells. This model could be used to test new anticancer drugs capable of inhibiting the spread of IBC tumors. "The tumor ...

Studies assess genetics, modified treatment to improve outcomes, reduce toxicity

2012-12-08

(ATLANTA, December 8, 2012) – Research identifying genetic factors that affect survival of patients with blood cancers and evaluating the effectiveness of modified treatment strategies to improve outcomes while reducing toxicity will be presented today at the 54th Annual Meeting of the American Society of Hematology (ASH). While the cancer research community has seen many significant therapeutic advances over the last decade, only recently have investigators identified how patients' individual genetic makeup influences their short- and long-term response to therapy, demonstrating ...

Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients

2012-12-08

COLUMBUS, Ohio – Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who have relapsed and are resistant to other therapy. The agent, ibrutinib (PCI-32765), is the first drug designed to target Bruton's tyrosine kinase (BTK), a protein essential for CLL-cell survival and proliferation. CLL is the most common form of leukemia, with about 15,000 new cases annually in the U.S. About 4,400 Americans die of the disease each year. Study co-leader Dr. ...

137 new species described by California Academy of Sciences in 2012

2012-12-08

SAN FRANCISCO (December 6, 2012) — In 2012, researchers at the California Academy of Sciences added 137 new relatives to our family tree, enriching our understanding of the complex web of life on Earth and strengthening our ability to make informed conservation decisions. The new species include 83 arthropods, 41 fishes, seven plants, four sea slugs, one reptile, and one amphibian. Specimens ranged from Eviota goby fishes housed in museum collections for more than 30 years (reported in the October 12 issue of Zootaxa), to Trogloraptor cave spiders collected just two years ...

Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients

2012-12-08

SAN ANTONIO, Texas -- Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium. VIDEO ALERT: Video of Dr. Perez is available on the Mayo Clinic News Network. A team ...

New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer

2012-12-08

SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic ...

Green scientists propose safety testing system for development of new chemicals

2012-12-08

PITTSBURGH—A group of scientists from North America and Europe, including Carnegie Mellon University's Terry Collins, has developed a five-tiered testing system that manufacturers can use to ensure that the chemicals and consumer products they produce are free of harmful endocrine disrupting chemicals like BPA or DDT. Their study, "Designing Endocrine Disruption Out of the Next Generation of Chemicals," will be published in the January 2013 issue of the Royal Society of Chemistry journal Green Chemistry, and is currently available online. Endocrine disrupting chemicals, ...

Greenland ice sheet carries evidence of increased atmospheric acidity

2012-12-08

Research has shown a decrease in levels of the isotope nitrogen-15 in core samples from Greenland ice starting around the time of the Industrial Revolution. The decrease has been attributed to a corresponding increase in nitrates associated with the burning of fossil fuels. However, new University of Washington research suggests that the decline in nitrogen-15 is more directly related to increased acidity in the atmosphere. The increased acidity can be traced to sulfur dioxide, which in the atmosphere is transformed to sulfuric acid, said Lei Geng, a UW research ...

Online Bingo at Its Best, Thanks to Bingo Reviewer!

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: